Nasdaq · CIK 0001833756
DRS Leonardo DRS, Inc.
Insider trading from SEC Form 4. Last filing 11 d ago. Close $36.24 on Oct 9, 2026, +12% from the 52-week low and -27% from the high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Leonardo DRS, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Mark Dorfman EVP, GC and Secretary sell | $277k 7,471 shares | -20% | - | |
| 42Moderate | Michael Dippold EVP and CFO sell | $755k 20,317 shares | -37% | - | |
| 48Moderate | Michael Dippold EVP and CFO sell | $739k 16,330 shares | -38% | +52% from low-6% from high | |
| 37Weak | Mark Dorfman EVP, GC and Secretary sell | $453k 10,014 shares | -36% | +52% from low-6% from high | |
| 38Weak | George Casey director sell | $68k 1,500 shares | -5% | +59% from low-3% from high | |
| 31Weak | Michael Dippold EVP and CFO sell | $392k 10,588 shares | -20% | +30% from low-23% from high | |
| 22Weak | Mark Dorfman EVP, GC and Secretary sell | $284k 7,680 shares | -22% | +30% from low-23% from high | |
| 22Weak | Michael Dippold EVP and CFO sell | $179k 5,294 shares | -9% | +16% from low-31% from high | |
| 14Weak | Mark Dorfman EVP, GC and Secretary sell | $130k 3,840 shares | -10% | +16% from low-31% from high | |
| 15Weak | John Baylouny EVP and COO sell | $371k 8,481 shares | -7% | +44% from low-17% from high | |
| 33Weak | John Baylouny EVP and COO sell | $477k 11,420 shares | -9% | +54% from low-14% from high | |
| 44Moderate | Michael Dippold EVP and CFO sell | $806k 19,360 shares | -25% | +56% from low-13% from high | |
| 33Weak | Mark Dorfman EVP, GC and Secretary sell | $533k 12,801 shares | -25% | +56% from low-13% from high | |
| 25Weak | John Baylouny EVP and COO sell | $468k 11,375 shares | -8% | +54% from low-15% from high | |
| 25Weak | Eric Salzman director sell | $181k 4,403 shares | -27% | +54% from low-15% from high | |
| 34Weak | David W Carey director sell | $296k 6,438 shares | -21% | +73% from low0% from high | |
| 35Weak | William Lynn III Chief Executive Officer sell | $1.8M 45,000 shares | -12% | +53% from low-2% from high | |
| 25Weak | John Baylouny EVP and COO sell | $113k 3,529 shares | -3% | +17% from low-16% from high | |
| 8Weak | Pamela Morrow SVP and Controller sell | $68k 2,150 shares | -10% | +27% from low-9% from high | |
| 2Weak | Sally Wallace EVP, Business Operations sell | $48k 1,498 shares | -2% | +27% from low-9% from high | |
| 35Weak | Michael Dippold EVP and CFO sell | $870k 26,618 shares | -28% | - | |
| 25Weak | Mark Dorfman EVP, GC and Secretary sell | $655k 20,034 shares | -30% | - | |
| 25Weak | John Baylouny EVP and COO sell | $108k 3,529 shares | -5% | - | |
| 10Weak | John Baylouny EVP and COO sell | $123k 3,529 shares | -5% | - | |
| 10Weak | John Baylouny EVP and COO sell | $113k 3,529 shares | -4% | - | |
| 29Weak | John Baylouny EVP and COO sell | $284k 8,235 shares | -9% | - | |
| 35Weak | Michael Dippold EVP and CFO sell | $882k 25,880 shares | -35% | - | |
| 27Weak | Mark Dorfman EVP, GC and Secretary sell | $785k 23,042 shares | -42% | - | |
| 11Weak | Sally Wallace EVP, Business Operations sell | $151k 4,339 shares | -13% | - | |
| 21Weak | Pamela Morrow SVP and Controller sell | $386k 11,100 shares | -47% | - | |
| 35Weak | William Lynn III Chief Executive Officer sell | $1.5M 45,000 shares | -16% | - |
Congressional trades
1 trade in DRS disclosed by members of Congress under the STOCK Act. All congressional trades.
- Julia LetlowHouse · R-LA · last Mar 12, 20261 bought
0 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Julia Letlow House · R-LA | Purchase | DRS Leonardo DRS, Inc. - Common Stock | $1,001 to $15k | Feb 2 / Mar 12 38 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Frances F Townsend director | MOption exercise Common Stock | +1,006 | $0.00 | $0 | 36,894 | 11 d ago |
| Sep 30, 2026 | Frances F Townsend director | MOption exercise Restricted Stock Unitderivative | -1,006 | $0.00 | $0 | 1,007 | 11 d ago |
| Sep 9, 2026 | Kenneth J Krieg director | GGift Common Stock | -3,700 | $0.00 | $0 | 27,576 | 32 d ago |
| Sep 4, 2026 | Mark Dorfman EVP, GC and Secretary | SOpen-market sale Common Stock10b5-1 | -7,471 | $37.01 | $277k | 29,271 | 34 d ago |
| Sep 2, 2026 | Michael Dippold EVP and CFO | SOpen-market sale Common Stock10b5-1 | -20,317 | $37.18 | $755k | 35,143 | 38 d ago |
| Mar 16, 2026 | Michael Dippold EVP and CFO | SOpen-market sale Common Stock10b5-1 | -16,330 | $45.27 | $739k | 26,622 | Mar 17, 2026 |
| Mar 16, 2026 | Mark Dorfman EVP, GC and Secretary | SOpen-market sale Common Stock10b5-1 | -10,014 | $45.27 | $453k | 17,666 | Mar 17, 2026 |
| Mar 4, 2026 | George Casey director | SOpen-market sale Common Stock | -1,500 | $45.14 | $68k | 28,820 | Mar 5, 2026 |
| Jan 5, 2026 | Mark Dorfman EVP, GC and Secretary | SOpen-market sale Common Stock10b5-1 | -7,680 | $37.00 | $284k | 27,680 | Jan 7, 2026 |
| Jan 5, 2026 | Michael Dippold EVP and CFO | SOpen-market sale Common Stock10b5-1 | -10,588 | $37.00 | $392k | 42,952 | Jan 7, 2026 |
| Dec 10, 2025 | William Lynn III Chief Executive Officer | GGift Common Stock | -10,000 | $0.00 | $0 | 312,382 | Dec 11, 2025 |
| Dec 1, 2025 | Michael Dippold EVP and CFO | SOpen-market sale Common Stock10b5-1 | -5,294 | $33.74 | $179k | 53,540 | Dec 2, 2025 |
| Dec 1, 2025 | Mark Dorfman EVP, GC and Secretary | SOpen-market sale Common Stock10b5-1 | -3,840 | $33.74 | $130k | 35,360 | Dec 2, 2025 |
| Nov 13, 2025 | Kenneth J Krieg director | GGift Common Stock | -2,600 | $0.00 | $0 | 27,720 | Nov 14, 2025 |
| Oct 15, 2025 | John Baylouny EVP and COO | SOpen-market sale Common Stock10b5-1 | -8,481 | $43.69 | $371k | 106,007 | Oct 16, 2025 |
| Sep 17, 2025 | John Baylouny EVP and COO | SOpen-market sale Common Stock10b5-1 | -11,420 | $41.78 | $477k | 114,488 | Sep 18, 2025 |
| Sep 12, 2025 | Michael Dippold EVP and CFO | SOpen-market sale Common Stock10b5-1 | -6,453 | $41.65 | $269k | 71,741 | Sep 15, 2025 |
| Sep 12, 2025 | Mark Dorfman EVP, GC and Secretary | SOpen-market sale Common Stock10b5-1 | -4,267 | $41.65 | $178k | 47,734 | Sep 15, 2025 |
| Sep 12, 2025 | Mark Dorfman EVP, GC and Secretary | SOpen-market sale Common Stock10b5-1 | -8,534 | $41.65 | $355k | 39,200 | Sep 15, 2025 |
| Sep 12, 2025 | Michael Dippold EVP and CFO | SOpen-market sale Common Stock10b5-1 | -12,907 | $41.65 | $538k | 58,834 | Sep 15, 2025 |
| Aug 20, 2025 | John Baylouny EVP and COO | SOpen-market sale Common Stock10b5-1 | -11,375 | $41.17 | $468k | 125,908 | Aug 21, 2025 |
| Aug 20, 2025 | Eric Salzman director | SOpen-market sale Common Stock10b5-1 | -4,403 | $41.17 | $181k | 11,820 | Aug 21, 2025 |
| Jun 13, 2025 | David W Carey director | SOpen-market sale Common Stock | -6,438 | $45.94 | $296k | 23,882 | Jun 16, 2025 |
| Jun 4, 2025 | Louis R Brothers Jr director | AGrant or award Restricted Stock Unitderivative | +3,556 | $0.00 | $0 | 3,556 | Jun 5, 2025 |
| Jun 4, 2025 | Gail Baker director | AGrant or award Restricted Stock Unitderivative | +3,556 | $0.00 | $0 | 3,556 | Jun 5, 2025 |
| Jun 4, 2025 | David W Carey director | AGrant or award Restricted Stock Unitderivative | +3,556 | $0.00 | $0 | 3,556 | Jun 5, 2025 |
| Jun 4, 2025 | George Casey director | AGrant or award Restricted Stock Unitderivative | +3,556 | $0.00 | $0 | 3,556 | Jun 5, 2025 |
| Jun 4, 2025 | Mary E Gallagher director | AGrant or award Restricted Stock Unitderivative | +3,556 | $0.00 | $0 | 3,556 | Jun 5, 2025 |
| Jun 4, 2025 | Kenneth J Krieg director | AGrant or award Restricted Stock Unitderivative | +3,556 | $0.00 | $0 | 3,556 | Jun 5, 2025 |
| Jun 4, 2025 | Eric Salzman director | AGrant or award Restricted Stock Unitderivative | +3,556 | $0.00 | $0 | 3,556 | Jun 5, 2025 |
| Jun 4, 2025 | Frances F Townsend director | AGrant or award Restricted Stock Unitderivative | +3,556 | $0.00 | $0 | 3,556 | Jun 5, 2025 |
| May 15, 2025 | Gail Baker director | MOption exercise Common Stock | +6,438 | $0.00 | $0 | 30,320 | May 16, 2025 |
| May 15, 2025 | Louis R Brothers Jr director | MOption exercise Common Stock | +6,438 | $0.00 | $0 | 20,760 | May 16, 2025 |
| May 15, 2025 | William Lynn III Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -45,000 | $40.77 | $1.8M | 322,382 | May 16, 2025 |
| May 15, 2025 | David W Carey director | MOption exercise Common Stock | +6,438 | $0.00 | $0 | 30,320 | May 16, 2025 |
| May 15, 2025 | George Casey director | MOption exercise Common Stock | +6,438 | $0.00 | $0 | 30,320 | May 16, 2025 |
| May 15, 2025 | Mary E Gallagher director | MOption exercise Common Stock | +6,438 | $0.00 | $0 | 30,320 | May 16, 2025 |
| May 15, 2025 | Frances F Townsend director | MOption exercise Common Stock | +6,438 | $0.00 | $0 | 30,320 | May 16, 2025 |
| May 15, 2025 | Kenneth J Krieg director | MOption exercise Common Stock | +6,438 | $0.00 | $0 | 30,320 | May 16, 2025 |
| May 15, 2025 | Eric Salzman director | MOption exercise Common Stock | +6,438 | $0.00 | $0 | 16,223 | May 16, 2025 |
| May 15, 2025 | Mary E Gallagher director | MOption exercise Restricted Stock Unitderivative | -6,438 | $0.00 | $0 | 0 | May 16, 2025 |
| May 15, 2025 | Gail Baker director | MOption exercise Restricted Stock Unitderivative | -6,438 | $0.00 | $0 | 0 | May 16, 2025 |
| May 15, 2025 | Louis R Brothers Jr director | MOption exercise Restricted Stock Unitderivative | -6,438 | $0.00 | $0 | 0 | May 16, 2025 |
| May 15, 2025 | David W Carey director | MOption exercise Restricted Stock Unitderivative | -6,438 | $0.00 | $0 | 0 | May 16, 2025 |
| May 15, 2025 | George Casey director | MOption exercise Restricted Stock Unitderivative | -6,438 | $0.00 | $0 | 0 | May 16, 2025 |
| May 15, 2025 | Kenneth J Krieg director | MOption exercise Restricted Stock Unitderivative | -6,438 | $0.00 | $0 | 0 | May 16, 2025 |
| May 15, 2025 | Eric Salzman director | MOption exercise Restricted Stock Unitderivative | -6,438 | $0.00 | $0 | 0 | May 16, 2025 |
| May 15, 2025 | Frances F Townsend director | MOption exercise Restricted Stock Unitderivative | -6,438 | $0.00 | $0 | 0 | May 16, 2025 |
| Apr 8, 2025 | John Baylouny EVP and COO | SOpen-market sale Common Stock10b5-1 | -3,529 | $31.96 | $113k | 137,283 | Apr 9, 2025 |
| Apr 3, 2025 | John Baylouny EVP and COO | AGrant or award Restricted Stock Unitderivative | +18,026 | $0.00 | $0 | 18,026 | Apr 4, 2025 |
| Apr 3, 2025 | Michael Dippold EVP and CFO | AGrant or award Restricted Stock Unitderivative | +16,353 | $0.00 | $0 | 16,353 | Apr 4, 2025 |
| Apr 3, 2025 | Mark Dorfman EVP, GC and Secretary | AGrant or award Restricted Stock Unitderivative | +10,344 | $0.00 | $0 | 10,344 | Apr 4, 2025 |
| Apr 3, 2025 | William Lynn III Chief Executive Officer | AGrant or award Restricted Stock Unitderivative | +68,605 | $0.00 | $0 | 68,605 | Apr 4, 2025 |
| Apr 3, 2025 | Sally Wallace EVP, Business Operations | AGrant or award Restricted Stock Unitderivative | +9,127 | $0.00 | $0 | 9,127 | Apr 4, 2025 |
| Apr 3, 2025 | Pamela Morrow SVP and Controller | AGrant or award Restricted Stock Unitderivative | +5,705 | $0.00 | $0 | 5,705 | Apr 4, 2025 |
| Apr 1, 2025 | Mark Dorfman EVP, GC and Secretary | MOption exercise Common Stock | +7,252 | $0.00 | $0 | 53,038 | Apr 3, 2025 |
| Apr 1, 2025 | Pamela Morrow SVP and Controller | MOption exercise Common Stock10b5-1 | +3,237 | $0.00 | $0 | 20,572 | Apr 3, 2025 |
| Apr 1, 2025 | Sally Wallace EVP, Business Operations | MOption exercise Common Stock10b5-1 | +7,252 | $0.00 | $0 | 62,412 | Apr 3, 2025 |
| Apr 1, 2025 | Mark Dorfman EVP, GC and Secretary | FTax withholding Common Stock | -3,503 | $32.87 | $115k | 49,535 | Apr 3, 2025 |
| Apr 1, 2025 | Pamela Morrow SVP and Controller | FTax withholding Common Stock10b5-1 | -1,262 | $32.87 | $41k | 19,310 | Apr 3, 2025 |
| Apr 1, 2025 | Sally Wallace EVP, Business Operations | FTax withholding Common Stock10b5-1 | -3,503 | $32.87 | $115k | 58,909 | Apr 3, 2025 |
| Apr 1, 2025 | Mark Dorfman EVP, GC and Secretary | MOption exercise Common Stock | +4,770 | $0.00 | $0 | 54,305 | Apr 3, 2025 |
| Apr 1, 2025 | Pamela Morrow SVP and Controller | MOption exercise Common Stock10b5-1 | +2,517 | $0.00 | $0 | 21,827 | Apr 3, 2025 |
| Apr 1, 2025 | Sally Wallace EVP, Business Operations | MOption exercise Common Stock10b5-1 | +4,337 | $0.00 | $0 | 63,246 | Apr 3, 2025 |
| Apr 1, 2025 | Mark Dorfman EVP, GC and Secretary | FTax withholding Common Stock | -2,304 | $32.87 | $76k | 52,001 | Apr 3, 2025 |
| Apr 1, 2025 | Pamela Morrow SVP and Controller | FTax withholding Common Stock10b5-1 | -1,183 | $32.87 | $39k | 20,644 | Apr 3, 2025 |
| Apr 1, 2025 | Sally Wallace EVP, Business Operations | FTax withholding Common Stock10b5-1 | -2,095 | $32.87 | $69k | 61,151 | Apr 3, 2025 |
| Apr 1, 2025 | Mark Dorfman EVP, GC and Secretary | MOption exercise Restricted Stock Unitderivative | -7,252 | $0.00 | $0 | 7,252 | Apr 3, 2025 |
| Apr 2, 2025 | Pamela Morrow SVP and Controller | SOpen-market sale Common Stock10b5-1 | -2,150 | $31.82 | $68k | 18,494 | Apr 3, 2025 |
| Apr 2, 2025 | Sally Wallace EVP, Business Operations | SOpen-market sale Common Stock10b5-1 | -1,498 | $31.82 | $48k | 59,653 | Apr 3, 2025 |
| Apr 1, 2025 | Mark Dorfman EVP, GC and Secretary | MOption exercise Restricted Stock Unitderivative | -4,770 | $0.00 | $0 | 9,542 | Apr 3, 2025 |
| Apr 1, 2025 | Pamela Morrow SVP and Controller | MOption exercise Restricted Stock Unitderivative10b5-1 | -3,237 | $0.00 | $0 | 10,790 | Apr 3, 2025 |
| Apr 1, 2025 | Sally Wallace EVP, Business Operations | MOption exercise Restricted Stock Unitderivative10b5-1 | -7,252 | $0.00 | $0 | 20,263 | Apr 3, 2025 |
| Apr 1, 2025 | Pamela Morrow SVP and Controller | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,517 | $0.00 | $0 | 8,273 | Apr 3, 2025 |
| Apr 1, 2025 | Sally Wallace EVP, Business Operations | MOption exercise Restricted Stock Unitderivative10b5-1 | -4,337 | $0.00 | $0 | 15,926 | Apr 3, 2025 |
| Apr 1, 2025 | Michael Dippold EVP and CFO | MOption exercise Common Stock | +10,360 | $0.00 | $0 | 79,162 | Apr 2, 2025 |
| Apr 1, 2025 | William Lynn III Chief Executive Officer | MOption exercise Common Stock | +46,361 | $0.00 | $0 | 374,765 | Apr 2, 2025 |
| Apr 1, 2025 | John Baylouny EVP and COO | MOption exercise Common Stock | +12,626 | $0.00 | $0 | 141,937 | Apr 2, 2025 |
| Apr 1, 2025 | Michael Dippold EVP and CFO | FTax withholding Common Stock | -4,673 | $32.87 | $154k | 74,489 | Apr 2, 2025 |
| Apr 1, 2025 | William Lynn III Chief Executive Officer | FTax withholding Common Stock | -23,227 | $32.87 | $763k | 351,538 | Apr 2, 2025 |
| Apr 1, 2025 | John Baylouny EVP and COO | FTax withholding Common Stock | -5,695 | $32.87 | $187k | 136,242 | Apr 2, 2025 |
| Apr 1, 2025 | Michael Dippold EVP and CFO | MOption exercise Common Stock | +6,815 | $0.00 | $0 | 81,304 | Apr 2, 2025 |
| Apr 1, 2025 | William Lynn III Chief Executive Officer | MOption exercise Common Stock | +31,753 | $0.00 | $0 | 383,291 | Apr 2, 2025 |
| Apr 1, 2025 | John Baylouny EVP and COO | MOption exercise Common Stock | +8,325 | $0.00 | $0 | 144,567 | Apr 2, 2025 |
| Apr 1, 2025 | Michael Dippold EVP and CFO | FTax withholding Common Stock | -3,074 | $32.87 | $101k | 78,230 | Apr 2, 2025 |
| Apr 1, 2025 | William Lynn III Chief Executive Officer | FTax withholding Common Stock | -15,909 | $32.87 | $523k | 367,382 | Apr 2, 2025 |
| Apr 1, 2025 | John Baylouny EVP and COO | FTax withholding Common Stock | -3,755 | $32.87 | $123k | 140,812 | Apr 2, 2025 |
| Apr 1, 2025 | Michael Dippold EVP and CFO | MOption exercise Restricted Stock Unitderivative | -10,360 | $0.00 | $0 | 10,360 | Apr 2, 2025 |
| Apr 1, 2025 | William Lynn III Chief Executive Officer | MOption exercise Restricted Stock Unitderivative | -46,361 | $0.00 | $0 | 46,361 | Apr 2, 2025 |
| Apr 1, 2025 | John Baylouny EVP and COO | MOption exercise Restricted Stock Unitderivative | -12,626 | $0.00 | $0 | 12,627 | Apr 2, 2025 |
| Apr 1, 2025 | Michael Dippold EVP and CFO | MOption exercise Restricted Stock Unitderivative | -6,815 | $0.00 | $0 | 13,631 | Apr 2, 2025 |
| Apr 1, 2025 | William Lynn III Chief Executive Officer | MOption exercise Restricted Stock Unitderivative | -31,753 | $0.00 | $0 | 63,507 | Apr 2, 2025 |
| Apr 1, 2025 | John Baylouny EVP and COO | MOption exercise Restricted Stock Unitderivative | -8,325 | $0.00 | $0 | 16,652 | Apr 2, 2025 |
| Mar 17, 2025 | John Baylouny EVP and COO | MOption exercise Common Stock | +41,698 | $0.00 | $0 | 112,974 | Mar 19, 2025 |
| Mar 17, 2025 | Mark Dorfman EVP, GC and Secretary | MOption exercise Common Stock10b5-1 | +23,949 | $0.00 | $0 | 56,380 | Mar 19, 2025 |
| Mar 17, 2025 | Michael Dippold EVP and CFO | MOption exercise Common Stock10b5-1 | +34,213 | $0.00 | $0 | 81,241 | Mar 19, 2025 |
| Mar 17, 2025 | Mark Dorfman EVP, GC and Secretary | FTax withholding Common Stock10b5-1 | -8,080 | $33.13 | $268k | 48,300 | Mar 19, 2025 |
| Mar 17, 2025 | Michael Dippold EVP and CFO | FTax withholding Common Stock10b5-1 | -11,036 | $33.13 | $366k | 70,205 | Mar 19, 2025 |
| Mar 17, 2025 | John Baylouny EVP and COO | FTax withholding Common Stock | -14,395 | $33.13 | $477k | 98,579 | Mar 19, 2025 |
| Mar 17, 2025 | Michael Dippold EVP and CFO | MOption exercise Common Stock10b5-1 | +32,422 | $0.00 | $0 | 102,627 | Mar 19, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Gail Bakerdirector
- John BaylounyEVP and COO
- Louis R Brothers Jrdirector
- David W Careydirector
- George Caseydirector
- Michael DippoldEVP and CFO
- Mark DorfmanEVP, GC and Secretary
- Mary E Gallagherdirector
- Kenneth J Kriegdirector
- William Lynn IIIChief Executive Officer
- Pamela MorrowSVP and Controller
- Eric Salzmandirector
- Frances F Townsenddirector
- Sally WallaceEVP, Business Operations
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.